{"DataElement":{"publicId":"2201085","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Most Recent Grade","preferredDefinition":"a numeric code to describe the severity of an adverse event using the most recent version defined for the Common Terminology Criteria for Adverse Events.","longName":"CTC_AE_MOSTREC_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2201084","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Most Recent Description","preferredDefinition":"information related to most recent version of the description or grade of an adverse experience reported using the Common Terminology Criteria for Adverse Events (CTCAE).","longName":"CTC_AE_MOSTREC_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207324","version":"1","preferredName":"Most Recent Description ","preferredDefinition":"Nearest to the present time.:Description; a statement that represents something in words.","longName":"C25577:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Most Recent","conceptCode":"C25577","definition":"Nearest to the present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2033-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ADEERS:NCI/CTEP Adverse Event Expedited Report System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1FA6AF5-5BB5-4E4E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"PWEST","dateCreated":"2005-03-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2016876","version":"6","preferredName":"Adverse Event Grade","preferredDefinition":"a numeric indicator that describes the severity of an adverse event as defined in CTCAE v3.0 with a permissible value of 0 to 5.","longName":"AE_GD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[{"value":"5","valueDescription":"DEATH RELATED TO ADVERSE EVENT","ValueMeaning":{"publicId":"2562274","version":"1","preferredName":"DEATH RELATED TO ADVERSE EVENT","longName":"2562274","preferredDefinition":"The termination of life as a result of an adverse event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Death Related to Adverse Event","conceptCode":"C48275","definition":"The termination of life associated with an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C04F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12D5-1125-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"0","valueDescription":"No adverse event or within normal limits","ValueMeaning":{"publicId":"2562273","version":"1","preferredName":"No adverse event or within normal limits","longName":"2562273","preferredDefinition":"NO ADVERSE EVENT OR WITHIN NORMAL LIMITS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C04E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"REEVESD","dateModified":"2009-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12D7-1125-E034-0003BA12F5E7","beginDate":"2002-11-14","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"1","valueDescription":"MILD ADVERSE EVENT","ValueMeaning":{"publicId":"2575939","version":"1","preferredName":"MILD ADVERSE EVENT","longName":"2575939","preferredDefinition":"An experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild Adverse Event","conceptCode":"C41338","definition":"An experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12D9-1125-E034-0003BA12F5E7","beginDate":"2002-11-14","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"MODERATE ADVERSE EVENT","ValueMeaning":{"publicId":"2575940","version":"1","preferredName":"MODERATE ADVERSE EVENT","longName":"2575940","preferredDefinition":"An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate Adverse Event","conceptCode":"C41339","definition":"An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12DB-1125-E034-0003BA12F5E7","beginDate":"2002-04-16","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"SEVERE ADVERSE EVENT","ValueMeaning":{"publicId":"2575941","version":"1","preferredName":"SEVERE ADVERSE EVENT","longName":"2575941","preferredDefinition":"Severe adverse event is an experience that requires therapeutic intervention. The event interrupts usual daily activities. If hospitalization is required for treatment it becomes a serious adverse event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Adverse Event","conceptCode":"C41340","definition":"An adverse event experience that requires intensive therapeutic intervention and interrupts usual daily activities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-17","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"FRAZIERP","dateModified":"2005-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12DD-1125-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"LIFE-THREATENING OR DISABLING ADVERSE EVENT","ValueMeaning":{"publicId":"2562276","version":"1","preferredName":"LIFE-THREATENING OR DISABLING ADVERSE EVENT","longName":"2562276","preferredDefinition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Life Threatening or Disabling Adverse Event","conceptCode":"C41337","definition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C051-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"CURTIST","dateModified":"2015-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2AF0537-12DF-1125-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTCAE:Common Terminology Criteria for Adverse Events v3.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2AF0537-12D1-1125-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-17","endDate":null,"createdBy":"PWEST","dateCreated":"2003-07-17","modifiedBy":"REEVESD","dateModified":"2009-09-23","changeDescription":"updated to meet criteria for CTCAE version 3.0","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812383","version":"1","longName":"AdEERS","context":"CTEP"},{"publicId":"2812032","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000132","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"},{"publicId":"10000210","version":"1","longName":"AdEERS","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"(Latest CTCAE Version) Grade","type":"Preferred Question Text","description":"(Latest CTCAE Version) Grade","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Grade","url":null,"context":"CTEP"},{"name":"1-COMMENT","type":"COMMENT","description":"Currently associated with the CTCAE version 3.0 value domain - a reference value domain will be created when caDSR 3.0 becomes available","url":null,"context":"CTEP"}],"origin":"ADEERS:NCI/CTEP Adverse Event Expedited Report System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F25D8D9F-17A5-0D98-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"PWEST","dateCreated":"2005-03-15","modifiedBy":"REEVESD","dateModified":"2011-04-15","changeDescription":"Currently associated with the CTCAE version 3.0 value domain - a reference value domain will be created when caDSR 3.0 becomes available","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}